SCHEMBL4020469

SCHEMBL4020469

CCCCNS(=O)(=O)c1ccccc1B(O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.62
CA9 Q16790 3/20 0.62
RECQL P46063 1/20 0.56
TSHR P16473 3/20 0.48
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C19 P33261 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
TP53 P04637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 6/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
LIPG Q9Y5X9 1/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
POLB P06746 1/20 0.42
BRD4 O60885 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956224 0.90 CA12 (0.60) CA12CA9RECQLTSHRCYP1A2
SCHEMBL29953983 0.83 CA12 (0.47) CA12CA9RECQLKMT2AALDH1A1
SCHEMBL9738489 0.81 CA12 (0.66) CA12CA9RECQLTSHRCYP1A2
SCHEMBL9738480 0.79 CA12 (0.63) CA12CA9RECQLTSHRCYP1A2
SCHEMBL31391062 0.79 CA12 (0.63) CA12CA9RECQLTSHRCYP1A2
SCHEMBL9462811 0.79 CA12 (0.63) CA12CA9RECQLTSHRCYP1A2
SCHEMBL635553 0.79 CA12 (0.63) CA12CA9RECQLTSHRCYP1A2
SCHEMBL13296442 0.78 CYP3A4 (0.65) CA12CA9RECQLTSHRCYP1A2
SCHEMBL18989501 0.78 CA9 (0.61) CA12CA9RECQLTSHRCYP1A2
SCHEMBL3978111 0.78 CA12 (0.61) CA12CA9RECQLTSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009098282-A1 LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY NOVASAID AB (SE) 2009-08-13 WO disclosed
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2003006451-A1 4-PHENYLPYRAN-2-ONE DERIVATIVES ALMIRALL PRODESFARMA S.A. (ES) 2003-01-23 WO disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed